Dr. Xiao Zhao, MD

Dr. Zhao practices at Trustees of Columbia University in the City of New York in New York, New York.

Dr. Zhao's NPI, 1144480914, was assigned on June 14, 2008. Dr. Zhao graduated from Icahn School Of Medicine At Mount Sinai in 2008. Dr. Zhao holds New York license 301273-01.

Dr. Zhao's primary practice is Trustees of Columbia University in the City of New York, at 630 W 168th St, New York, NY 10032 in New York County. The practice phone is (212) 342-5155.

Dr. Zhao's primary practice is Trustees of Columbia University in the City of New York in New York, New York. Dr. Zhao is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Dr. Zhao to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zhao practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Zhao's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dmand AI has Dr. Zhao's licenses on file in 3 states: New York, Connecticut and Pennsylvania.

Dmand AI lists acid reflux, colonoscopy, gastroenteritis, irritable bowel syndrome (IBS) and upper GI endoscopy among the conditions Dr. Zhao treats.

CMS data shows 57 Medicare services from Dr. Zhao across 2 procedure codes in 2024, for 72 Medicare patients. Medicare paid $3,870 for them.

CMS counts 72 Medicare patients who saw Dr. Zhao in 2024. The largest group is 65 to 74, with 31 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 51% are also on Medicaid. Their average risk score is 2.97, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Zhao's median patient age at 55, with 61% women.

In 2024, Dr. Zhao wrote 135 Medicare Part D claims for 58 patients. 67% of them were for generic drugs. CMS names the drug for 96 of them, across 5 drugs with 11 or more claims each, at $43,557 in total drug cost. In 2023, CMS named 104 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Zhao for performance year 2024, reported through an alternative payment model (APM). Dr. Zhao accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Zhao as offering telehealth. CMS counts 20 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Zhao, more than 50% of the clinicians it reports for that procedure.

Dmand AI links 45 papers to Dr. Zhao, published from 2013 to 2025. 2020 was the busiest year, with 8. The most frequent topics are Water Pollutants, Chemical, Petroleum Pollution and Biliary Atresia. Dr. Zhao has published most often in Mar Pollut Bull. Dr. Zhao's most frequent co-authors are Naifa L. Busaidy, MD, Ramona Dadu, MD and Mark Edwin Zafereo, MD.

CMS Open Payments shows 88 general payments to Dr. Zhao from 9 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Bausch Health Americas, Inc. paid the most, $1,120.

Dr. Zhao graduated from Icahn School Of Medicine At Mount Sinai in 2008.

Dr. Zhao is in network with 12 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.